Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: Mesa Laboratories, Inc.

Market Cap 525M 458M 424M 397M 745M 49.58B 749M 5.03B 1.95B 24.4B 1.97B 1.93B 84.73B P/E 2027 *
69.9x
P/E 2028 * 44.4x
Enterprise Value 525M 458M 424M 397M 745M 49.58B 749M 5.03B 1.95B 24.4B 1.97B 1.93B 84.73B EV / Sales 2027 *
2.03x
EV / Sales 2028 * 1.93x
Free-Float
94.37%
Yield 2027 *
0.67%
Yield 2028 * 0.67%
1 day+0.16%
1 week-9.84%
Current month-6.78%
1 month-12.84%
3 months+18.88%
6 months+17.35%
Current year+21.15%
1 week 93.62
Extreme 93.62
106.49
1 month 81.3
Extreme 81.3
113.99
Current year 71.06
Extreme 71.065
113.99
1 year 55.45
Extreme 55.45
113.99
3 years 55.45
Extreme 55.45
155.12
5 years 55.45
Extreme 55.45
333.42
10 years 55.45
Extreme 55.45
333.42
Manager TitleAgeSince
Chief Executive Officer 56 2026-04-11
Director of Finance/CFO 57 2012-10-28
Comptroller/Controller/Auditor 41 2021-12-31
Director TitleAgeSince
Chairman 73 2017-08-31
Director/Board Member 57 2019-03-03
Director/Board Member 57 2020-05-10
Date Insider Type Main position Quantity % Market Cap.
Jun. 15Sell

Executive/Senior Manager

-1,151 0.0208%
Jun. 15Sell

Chief Financial Officer

-1,223 0.0221%
Jun. 15Sell

Controller/Auditor

-118 0.0021%
Change 5-day change 1-year change 3-year change Capi.($)
+0.16%-9.84%-0.75%-27.77% 525M
-0.10%+0.26%-33.52%-16.79% 154B
+1.54%-1.07%-8.11%-10.17% 102B
-0.99%+1.30%+58.58%+58.49% 56.51B
-1.90%-3.49%-7.43%+46.28% 52.89B
+1.67%-1.55%-14.51%-44.04% 39.67B
-1.32%-1.83% - - 30.39B
+1.74%-3.85%-9.41%-43.32% 27.96B
+1.35%-0.26%+51.96%-11.10% 23.17B
+0.90%+0.34%-16.09%-3.59% 20.35B
Average +0.31%-2.31%+2.30%-5.78% 50.7B
Weighted average by Cap. +0.22%-1.25%-6.36%-2.45%

Financials

2027 *2028 *
Net sales 259M 226M 209M 196M 367M 24.45B 370M 2.48B 962M 12.04B 973M 952M 41.8B 272M 237M 220M 206M 386M 25.68B 388M 2.61B 1.01B 12.64B 1.02B 1B 43.89B
Net income 7.57M 6.6M 6.11M 5.72M 10.73M 714M 10.79M 72.49M 28.09M 351M 28.4M 27.79M 1.22B 12.13M 10.58M 9.8M 9.17M 17.2M 1.14B 17.31M 116M 45.05M 564M 45.54M 44.57M 1.96B
Net Debt - -
Logo Mesa Laboratories, Inc.
Mesa Laboratories, Inc. designs and manufactures life sciences tools and critical control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. The Company's segments include Sterilization and Disinfection Control, Clinical Genomics, Biopharmaceutical Development, and Calibration Solutions. Sterilization and Disinfection Control segment manufactures and sells biological, chemical and cleaning indicators. Clinical Genomics segment develops, manufactures and sells genetic analysis tools and related consumables and services. Biopharmaceutical Development segment develops, manufactures, sells and services automated systems for protein analysis and peptide synthesis solutions. Calibration Solutions segment develops, manufactures, sells and services control products using principles of advanced metrology to enable customers to measure and calibrate critical parameters in applications, such as renal care, environmental and process monitoring.
Employees
717
Date Price Change Volume
26-06-18 95.10 $ +0.16% 174,251
26-06-17 94.95 $ -4.75% 272,495
26-06-16 99.68 $ -4.23% 260,933
26-06-15 104.08 $ -1.33% 559,040
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
95.10USD
Average target price
112.00USD
Spread / Average Target
+17.77%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MLAB Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!